Tag: Eczema
Lebrikizumab Tied to Sustained Atopic Dermatitis Treatment Effect
Findings seen despite negligible remaining lebrikizumab serum concentrations following treatment withdrawal
1.5 Percent Ruxolitinib Cream Safe, Effective for Teens With Eczema
Ruxolitinib cream well tolerated, and disease control maintained over a year with as-needed use
AAD: Lebrikizumab Shows Efficacy in Skin-of-Color Patients With Atopic Dermatitis
Among patients with atopic dermatitis and self-reported race other than White, 68.3 percent achieved EASI 75 at week 16
Atopic Dermatitis in Children Tied to Learning, Memory Difficulties
However, finding limited to children with neurodevelopmental comorbidities, like ADHD or learning disabilities
Climatic Hazards Linked to Aggravation of Atopic Dermatitis
Evidence of aggravation of AD seen for most climatic hazards, with impact ranging from direct to indirect effects
Skin Clinic Visits Increased With High Carbon Monoxide Levels Due to Wildfires
Atypical summer peak CO levels in Boston region in 2023 linked to spike in AD, dermatitis, eczema-related clinic visits
Updated Guidelines Released for Management of Atopic Dermatitis
Changes in this update include guidance on shared decision-making, factors to consider for each recommendation
Recommendations Developed for Atopic Dermatitis Therapies
Guidelines include strong recommendations for monoclonal antibodies and JAK inhibitors
Lymphoid Reaction Observed in Eczema Patients Receiving Dupilumab
Histopathologic findings included sprinkled distribution of small hyperchromatic lymphocytes in the upper epidermal section
Teens With Atopic Dermatitis More Likely to Experience Bullying
Adolescents with atopic dermatitis have higher odds of being bullied at higher frequency after adjustment for demographics, atopic comorbidities